Related Experiment Video

Updated: Jul 16, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Oncolytic viruses in cancer therapy

Markus J V Vähä-Koskela1, Jari E Heikkilä, Ari E Hinkkanen

  • 1Abo Akademi University, Department of Biochemistry and Pharmacy and Turku Immunology Centre, Turku, Finland. makoskel@abo.fi

Cancer Letters
|March 27, 2007
PubMed

Insights

Oncolytic virotherapy uses viruses to target and destroy cancer cells, offering a novel gene therapy approach. Research highlights various oncolytic viruses and challenges like tumor cell resistance.

Area of Science:

  • Oncology
  • Gene Therapy
  • Virology

Background:

  • Oncolytic virotherapy is an emerging cancer treatment strategy.
  • It utilizes naturally occurring or modified viruses to selectively infect and lyse cancer cells.
  • This approach offers a targeted alternative to traditional cancer therapies.

Purpose of the Study:

  • To introduce the field of oncolytic virotherapy.
  • To review current observations, insights, and emerging ideas in the literature.
  • To provide a broad overview of various oncolytic viruses used in cancer research.

Main Methods:

  • Literature review of oncolytic virotherapy research.
  • Identification and cataloging of diverse oncolytic viruses.
  • Discussion of current research trends and challenges.

Main Results:

  • Identified numerous oncolytic viruses, including avian adenovirus, foamy virus, myxoma virus, and others.
  • Highlighted the potential of viruses like echovirus type 1 and bovine herpesvirus 4.
  • Acknowledged the inclusion of novel agents such as Sendai virus and non-human coronaviruses.

Conclusions:

  • Oncolytic virotherapy shows significant promise as a cancer gene therapy.
  • Continued research is essential to overcome challenges like virus-resistant tumor cells.
  • The diversity of oncolytic viruses offers a broad spectrum of therapeutic possibilities.

More Related Videos

Ex Vivo Infection of Live Tissue with Oncolytic Viruses12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...